"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
“美國食品藥品管理局專家委員會將在下個月審查創傷後應激障礙的****輔助療法”-大麻時刻
The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), scheduling a meeting next month where an expert committee will examine the evidence behind the application.
美國食品藥品監督管理局（FDA）正在對用於治療創傷後應激障礙（PTSD）的****輔助療法進行歷史性審查，並計劃在下個月舉行一次會議，專家委員會將審查該申請背後的證據。
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) announced on Monday that FDA's Psychopharmacologic Drugs Advisory Committee will meet on June 4 to review the results of its clinical trials for the psychedelic-assisted therapy.
Lykos Therapeutics（前身爲MAPS公益公司）週一宣佈，美國食品藥品管理局的精神藥理藥物諮詢委員會將於6月4日舉行會議，審查其迷幻輔助療法的臨床試驗結果。
Not only will this be the first time in 25 years since FDA has reviewed a new PTSD treatment option, it's the...
這不僅是自美國食品藥品管理局審查新的創傷後應...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。